Cargando…
Tamoxifen resistance-related ceRNA network for breast cancer
Background: Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its application, rendering it crucial to explore the mechanisms of TMX resistance in BC. This aims of this study were to identify the mechanism...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733938/ https://www.ncbi.nlm.nih.gov/pubmed/36506097 http://dx.doi.org/10.3389/fcell.2022.1023079 |
_version_ | 1784846483800981504 |
---|---|
author | Qiao, Zipeng Xing, Yu Zhang, Qingquan Tang, Yongjun Feng, Ruifa Pang, Weiyi |
author_facet | Qiao, Zipeng Xing, Yu Zhang, Qingquan Tang, Yongjun Feng, Ruifa Pang, Weiyi |
author_sort | Qiao, Zipeng |
collection | PubMed |
description | Background: Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its application, rendering it crucial to explore the mechanisms of TMX resistance in BC. This aims of this study were to identify the mechanisms of TMX resistance and construct ceRNA regulatory networks in breast cancer. Methods: GEO2R was used to screen for differentially expressed mRNAs (DEmRNAs) leading to drug resistance in BC cells. MiRTarbase and miRNet were used to predict miRNAs and lncRNAs upstream, and the competing endogenous RNA (ceRNA) regulatory network of BC cell resistance was constructed by starBase. We used the Kaplan–Meier plotter and Gene Expression Profiling Interactive Analysis (GEPIA) to analyze the expression and prognostic differences of genes in the ceRNA network with core axis, and qRT-PCR was used to further verify the above conclusions. Results: We found that 21 DEmRNAs were upregulated and 43 DEmRNA downregulated in drug-resistant BC cells. DEmRNAs were noticeably enriched in pathways relevant to cancer. We then constructed a protein-protein interaction (PPI) network based on the STRING database and defined 10 top-ranked hub genes among the upregulated and downregulated DEmRNAs. The 20 DEmRNAs were predicted to obtain 113 upstream miRNAs and 501 lncRNAs. Among them, 7 mRNAs, 22 lncRNAs, and 11 miRNAs were used to structure the ceRNA regulatory network of drug resistance in BC cells. 4 mRNAs, 4 lncRNAs, and 3 miRNAs were detected by GEPIA and the Kaplan–Meier plotter to be significantly associated with BC expression and prognosis. The differential expression of the genes in BC cells was confirmed by qRT-PCR. Conclusion: The ceRNA regulatory network of TMX-resistant BC was successfully constructed and confirmed. This will provide an important resource for finding therapeutic targets for TMX resistance, where the discovery of candidate conventional mechanisms can aid clinical decision-making. In addition, this resource will help discover the mechanisms behind this type of resistance. |
format | Online Article Text |
id | pubmed-9733938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97339382022-12-10 Tamoxifen resistance-related ceRNA network for breast cancer Qiao, Zipeng Xing, Yu Zhang, Qingquan Tang, Yongjun Feng, Ruifa Pang, Weiyi Front Cell Dev Biol Cell and Developmental Biology Background: Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its application, rendering it crucial to explore the mechanisms of TMX resistance in BC. This aims of this study were to identify the mechanisms of TMX resistance and construct ceRNA regulatory networks in breast cancer. Methods: GEO2R was used to screen for differentially expressed mRNAs (DEmRNAs) leading to drug resistance in BC cells. MiRTarbase and miRNet were used to predict miRNAs and lncRNAs upstream, and the competing endogenous RNA (ceRNA) regulatory network of BC cell resistance was constructed by starBase. We used the Kaplan–Meier plotter and Gene Expression Profiling Interactive Analysis (GEPIA) to analyze the expression and prognostic differences of genes in the ceRNA network with core axis, and qRT-PCR was used to further verify the above conclusions. Results: We found that 21 DEmRNAs were upregulated and 43 DEmRNA downregulated in drug-resistant BC cells. DEmRNAs were noticeably enriched in pathways relevant to cancer. We then constructed a protein-protein interaction (PPI) network based on the STRING database and defined 10 top-ranked hub genes among the upregulated and downregulated DEmRNAs. The 20 DEmRNAs were predicted to obtain 113 upstream miRNAs and 501 lncRNAs. Among them, 7 mRNAs, 22 lncRNAs, and 11 miRNAs were used to structure the ceRNA regulatory network of drug resistance in BC cells. 4 mRNAs, 4 lncRNAs, and 3 miRNAs were detected by GEPIA and the Kaplan–Meier plotter to be significantly associated with BC expression and prognosis. The differential expression of the genes in BC cells was confirmed by qRT-PCR. Conclusion: The ceRNA regulatory network of TMX-resistant BC was successfully constructed and confirmed. This will provide an important resource for finding therapeutic targets for TMX resistance, where the discovery of candidate conventional mechanisms can aid clinical decision-making. In addition, this resource will help discover the mechanisms behind this type of resistance. Frontiers Media S.A. 2022-11-25 /pmc/articles/PMC9733938/ /pubmed/36506097 http://dx.doi.org/10.3389/fcell.2022.1023079 Text en Copyright © 2022 Qiao, Xing, Zhang, Tang, Feng and Pang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Qiao, Zipeng Xing, Yu Zhang, Qingquan Tang, Yongjun Feng, Ruifa Pang, Weiyi Tamoxifen resistance-related ceRNA network for breast cancer |
title | Tamoxifen resistance-related ceRNA network for breast cancer |
title_full | Tamoxifen resistance-related ceRNA network for breast cancer |
title_fullStr | Tamoxifen resistance-related ceRNA network for breast cancer |
title_full_unstemmed | Tamoxifen resistance-related ceRNA network for breast cancer |
title_short | Tamoxifen resistance-related ceRNA network for breast cancer |
title_sort | tamoxifen resistance-related cerna network for breast cancer |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733938/ https://www.ncbi.nlm.nih.gov/pubmed/36506097 http://dx.doi.org/10.3389/fcell.2022.1023079 |
work_keys_str_mv | AT qiaozipeng tamoxifenresistancerelatedcernanetworkforbreastcancer AT xingyu tamoxifenresistancerelatedcernanetworkforbreastcancer AT zhangqingquan tamoxifenresistancerelatedcernanetworkforbreastcancer AT tangyongjun tamoxifenresistancerelatedcernanetworkforbreastcancer AT fengruifa tamoxifenresistancerelatedcernanetworkforbreastcancer AT pangweiyi tamoxifenresistancerelatedcernanetworkforbreastcancer |